What are the benefits of Kineret®
Kineret® has been used in RA patients for over 12 years. Kineret® has been studied alone and in combination with other DMARDs. In clinical studies, most patients have experienced improvement of their rheumatoid arthritis (RA) symptoms within 12 weeks after beginning treatment with Kineret®. In the clinical studies, significant improvement in signs and symptoms of RA was seen in patients on Kineret for 3-6 months as measured by the American College of Rheumatology (ACR) response criteria. This improvement was measured by a combination of physician assessment of joints and pain, objective measures and patient reported outcomes, including improvement in performing daily tasks, such as dressing and grooming, arising, eating, walking, reaching, gripping and activities related to hygiene. These people also reported substantial relief of many of the symptoms associated with RA. After a year of treatment, Kineret® slowed the progression of joint erosion and cartilage degradation in these patients with active RA.
Important Safety Information
Kineret may cause serious side effects, including serious infections, blood problems (a decrease in the number of neutrophils in the blood, especially when used with TNF-blocking agents), and allergic reactions.
The most common side effects of Kineret® for RA include injection-site reactions, including redness, swelling, bruising, itching, and stinging. Most injection-site reactions are mild, happen early during treatment, and last about 14 to 28 days.
Other common side effects of Kineret® for RA include sore throat or runny nose (including sinus infections), joint pain, headaches, nausea, diarrhea, pain in your stomach area, feeling like you have the flu, and worsening of RA.
Please see additional Important Safety Information below.